Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Congress-2020-1000x250

Genitourinary Tumours (Non-Prostate)

Harnessing the Potential of The Immune System: Clinical Insights from Utilizing CTLA-4 within a Dual I-O Approach in aRCC

03-Harnessing-the-Potential-of-The-Immune-System-BMS-Thumb

On Demand Session
View the satellite invitation

2020: New Decade, New Treatment Choices in GU Cancer (Medical)

32-2020-New-Decade-New-Treatment-Choices-in-GU-Cancer-MERCK-PFIZER-ALLIANCE-Thumb

On Demand Session
View the satellite invitation

What Does the Changing Treatment Landscape for aRCC Mean for Patient Care: An Expert Discussion

42-What-Does-the-Changing-Treatment-Landscape-for-aRCC-Mean-IPSEN-Thumb

On Demand Session
View the satellite invitation

Multiple Immunotherapeutic Options: Clinical Decision Making in Advanced Renal Cell Carcinoma and Urothelial Carcinoma

47--Multiple-Immunotherapeutic-Options-MSD-Thumb

On Demand Session
View the satellite invitation

Reshaping Treatment Paradigms for GU Cancer Patients: Perspectives on PI3K/AKT Inhibitors in mCRPC and Immunotherapy in Urothelial Cancer

55-Reshaping-Treatment-Paradigms-for-GU-Cancer-Patients-ROCHE-Thumb

On Demand Session
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Virtual Congress 2020 Industry Sponsored Satellite Symposia Programme

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings